# GSP Distribution (Division Groupe GSP Inc.), Québec, Canada – FDA Inspections

Source: https://www.keypedia.com/companies/gsp-distribution-division-groupe-gsp-inc/d3bab28b-701b-49eb-b4d7-df3fa51a081e

> Inspection records and compliance data for GSP Distribution (Division Groupe GSP Inc.) in Québec, Quebec. Access full analysis and detailed observations.

---

## Details

- Name: GSP Distribution (Division Groupe GSP Inc.)
- Address Line 1: 5300 Boul. Des Galeries
- City: Québec
- State: Quebec
- Zip Code: G2K 2A2
- Country Name: Canada
- Address: 5300 Boul. Des Galeries, Québec, Quebec G2K 2A2, Canada
- Country: Canada

## Related Documents

- Canada Inspection - GSP Distribution (Division Groupe GSP Inc.) - Inspection #76711 - 2021-06-14 — source: Canada, date: June 14, 2021

## Related Companies

- [Sante Animale Anivet Inc.](https://www.keypedia.com/companies/sante-animale-anivet-inc/0c0ec7ab-c500-427d-b177-b7a9d0d2a640)
- [Médi-Sélect Ltée](https://www.keypedia.com/companies/medi-select-ltee/80a9d182-ef94-4977-84e6-9e60afbb84bf)
- [Avi-Life Lab inc.](https://www.keypedia.com/companies/avi-life-lab-inc/bc2a034b-468c-412d-b160-edda0c703905)
- [Nu Foilprint Inc.](https://www.keypedia.com/companies/nu-foilprint-inc/36f2bf39-59ca-4681-90c9-f52f7c286243)
- [Famar Montréal Inc.](https://www.keypedia.com/companies/famar-montreal-inc/decd20ed-09eb-485f-a41d-215c7185df71)
- [Chem-Actives Inc.](https://www.keypedia.com/companies/chem-actives-inc/a6a9e0c0-4f6e-4923-9f1b-14a6f516e5d9)
- [Endoceutics Pharma (MSH) Inc.](https://www.keypedia.com/companies/endoceutics-pharma-msh-inc/4441e727-7eb1-4816-877d-bffe05283d36)
- [Pfizer Canada Inc., Animal Health Group](https://www.keypedia.com/companies/pfizer-canada-inc-animal-health-group/d5861f67-ca1e-4bf7-a8de-648fc3981d07)
- [Kamins Dermatologics Inc.](https://www.keypedia.com/companies/kamins-dermatologics-inc/47cc528c-1a67-4394-883d-40f95309c63d)
- [Karibuni International Inc.](https://www.keypedia.com/companies/karibuni-international-inc/a478bedf-9c98-4522-a388-b65788cea8c1)